Acorda Therapeutics to Host Analyst and Investor Reception
Business Wire (press release) - San Francisco,CA,USA
The platform presentation of the Phase 3 clinical trial of Fampridine-SR data at the AAN meeting will take place on May 2, 2007 at 4:15 pm ET. ...
See all stories on this topic